2017

Novel fMRI applications in childhood epilepsy increase understanding of seizure impacts on a child’s brain

Functional magnetic resonance imaging (fMRI) has allowed researchers to map the memory functions that are often impaired within the brains of children with epilepsy. Additionally, a separate study of a novel application of resting-state fMRI, where the patient does not have to complete tasks, demonstrated the potential for clinicians to use non-invasive fMRI for language assessment for children who are too young or impaired to follow task directions in traditional fMRI studies. Both studies were presented at the American Epilepsy Society Annual Meeting in Washington, D.C., last week. 
2017 Leapfrog Top Children's Hopsital Award

Children’s National Health System named a Leapfrog Group Top Hospital

Children’s National Health System has been named a Leapfrog Group Top Hospital for 2017; one of only 10 children’s hospitals in the United States and the only one in the mid-Atlantic region. This is the ninth time that Children’s National has earned this prestigious designation given to hospitals with distinct achievements in patient safety and quality including lower infection rates, decreased lengths of stay and fewer readmissions.

Read more

Children’s National Health System breaks ground in Prince George’s County

Children’s National Health System held a ceremonial groundbreaking today at Woodmore Towne Center in Glenarden, Md., the future site of a comprehensive pediatric outpatient and specialty care center slated to open in 2020. The planned 60,000 square foot facility is the latest effort to ensure kids and their families can easily and conveniently access Children’s National specialists and primary care providers.

Children's National promotes Capital of Caring to support all kids

This holiday season, Children’s National has launched a multi-media campaign to mobilize the Washington metropolitan area in support of children – the Capital of Caring campaign. The campaign honors the hospital’s longstanding commitment to children and families in the Washington area, featuring iconic imagery of notable monuments.

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy, offer long-term benefits for this disease, including longer preservation of muscle strength and function and decreased risk of death. These findings support the standard prescribing practices in many clinics and could help sway parents who are on the fence about their children receiving these therapies, say authors of a study published online Nov. 22, 2017 in The Lancet.